Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Geron Corp (NQ: GERN )

1.860 USD -0.030 (-1.59%)
Streaming Delayed Price Updated: 9:28 AM EST, Feb 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Geron Corp

< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 431,600 shares of Geron common stock as inducements to newly hired employees... 
From Business Wire News Releases
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 120,000 shares of Geron common stock as inducements to newly hired employees... 
From Business Wire News Releases
Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will present a company overview at... 
From Business Wire News Releases
Geron Announces Opening of IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the opening for patient screening and enrollment of the IMpactMF Phase 3 clinical trial of imetelstat,... 
From Business Wire News Releases
Geron Announces Fifty Percent Enrollment Milestone in IMerge Phase 3 Clinical Trial in Lower Risk MDS
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced achievement of fifty percent enrollment in the IMerge Phase 3 clinical trial of imetelstat in lower... 
From Business Wire News Releases
Geron Reports Ten Imetelstat Presentations at American Society of Hematology Annual Meeting
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that four oral presentations and six poster presentations containing clinical data and analyses... 
From Business Wire News Releases
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 80,000 shares of Geron common stock as an inducement to a newly-hired... 
From Business Wire News Releases
Geron to Present at the Stifel Virtual Healthcare Conference
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will present a company overview at... 
From Business Wire News Releases
Geron Corporation Reports Third Quarter 2020 Financial Results and Current Events
From GlobeNewswire News Releases
Geron Announces Ten Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that ten abstracts containing clinical data and analyses related to imetelstat, the Company’s... 
From Business Wire News Releases
Geron to Announce Third Quarter Financial Results on November 5, 2020
Geron Corporation (Nasdaq: GERN) today announced that it will release its third quarter 2020 financial results after the market closes on Thursday, November 5, 2020 via press release, which will be... 
From Business Wire News Releases
Geron Announces Publication of IMerge Phase 2 Data in Journal of Clinical Oncology
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that data from the IMerge Phase 2 trial were published in the Journal of Clinical Oncology. The... 
From Business Wire News Releases
Geron Secures Loan Facility for Up to $75 Million
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it has entered into a loan facility for up to $75 million with Hercules Capital, Inc. (NYSE:... 
From Business Wire News Releases
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 80,000 shares of Geron common stock as an inducement to a newly-hired... 
From Business Wire News Releases
Geron to Present at the H.C. Wainwright Global Investment Conference
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will present a company overview at... 
From Business Wire News Releases
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 270,000 shares of Geron common stock as inducements to four newly-hired... 
From Business Wire News Releases
Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2020. The Company will host a conference call... 
From Business Wire News Releases
Geron to Present at the BTIG Virtual Biotechnology Conference
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will participate in a fireside chat... 
From Business Wire News Releases
Geron to Announce Second Quarter Financial Results on August 6, 2020
Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2020 financial results after the market closes on Thursday, August 6, 2020 via press release, which will be... 
From Business Wire News Releases
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 150,000 shares of Geron common stock as an inducement to a newly-hired... 
From Business Wire News Releases
Geron Receives Positive Opinion from the EMA Committee for Orphan Medicinal Products for Orphan Drug Designation in the European Union for Imetelstat to Treat Myelodysplastic Syndromes
From GlobeNewswire News Releases
Geron Reports Four Imetelstat Data Presentations at Virtual Edition of the European Hematology Association (EHA) Annual Congress
From GlobeNewswire News Releases
Geron Corporation Reports First Quarter 2020 Financial Results
From GlobeNewswire News Releases
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
From GlobeNewswire News Releases
Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants
From GlobeNewswire News Releases
Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants
From GlobeNewswire News Releases
Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates
From GlobeNewswire News Releases
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 70,000 shares of Geron common stock as an inducement to a newly-hired... 
From Business Wire News Releases
Geron Announces Four Imetelstat Presentations at the Virtual Edition of the European Hematology Association Annual Congress
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that four abstracts containing new clinical data and analyses related to imetelstat, the Company’s... 
From Business Wire News Releases
Geron Corporation (NASDAQ: GERN) Long Term Investor Alert: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 04/30/2020 -- An investigation on behalf of current long term investors in Geron Corporation (NASDAQ: GERN) shares over possible breaches of fiduciary duty by certain... 
From SBWire - Latest Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback